NeoVirTech is a biotechnology company developing autofluorescent viruses and viral vectors for the discovery of new antiviral compounds, oncolytic vectors or gene therapies. The company uses its proprietary system called ANCHOR that allow for the first time real time visualisation of viral DNA localisation and replication in living cells. Combined with the power of high content screening microscopes, this techniques unleash next generation antiviral screening, with high speed and high precision. NeoVirTech is a spin off of the ITAV and focus its activity on the human, animal and biodefense market. The company was awarded by the french ministry of research in 2013 and 2016 for its unique innovation.